Janux Therapeutics Inc
NASDAQ:JANX
Janux Therapeutics Inc
NASDAQ:JANX
Price:
47.51 USD
0.06%
Updated:
May 17, 2024
Balance Sheet
Balance Sheet Decomposition
Janux Therapeutics Inc
Janux Therapeutics Inc
| Current Assets | 658.7m |
| Cash & Short-Term Investments | 651.8m |
| Receivables | 519k |
| Other Current Assets | 6.4m |
| Non-Current Assets | 30.3m |
| PP&E | 27m |
| Other Non-Current Assets | 3.3m |
| Current Liabilities | 10.6m |
| Accounts Payable | 2.3m |
| Accrued Liabilities | 7.4m |
| Other Current Liabilities | 972k |
| Non-Current Liabilities | 22.6m |
| Other Non-Current Liabilities | 22.6m |
Balance Sheet
Janux Therapeutics Inc
Janux Therapeutics Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
1
|
8
|
36
|
51
|
19
|
|
| Cash |
1
|
8
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
36
|
51
|
19
|
|
| Short-Term Investments |
0
|
0
|
339
|
276
|
325
|
|
| Total Receivables |
0
|
8
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
8
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
5
|
5
|
|
| Total Current Assets |
1
|
16
|
377
|
332
|
349
|
|
| PP&E Net |
0
|
0
|
2
|
29
|
28
|
|
| PP&E Gross |
0
|
0
|
2
|
29
|
28
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
2
|
3
|
|
| Total Assets |
1
N/A
|
16
+2 214%
|
380
+2 244%
|
364
-4%
|
380
+5%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
0
|
3
|
2
|
2
|
|
| Accrued Liabilities |
0
|
1
|
4
|
9
|
9
|
|
| Short-Term Debt |
4
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
2
|
6
|
6
|
2
|
|
| Total Current Liabilities |
5
|
3
|
13
|
17
|
13
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
6
|
1
|
27
|
23
|
|
| Total Liabilities |
5
N/A
|
9
+100%
|
14
+47%
|
43
+221%
|
36
-17%
|
|
| Equity | ||||||
| Common Stock |
4
|
22
|
0
|
0
|
0
|
|
| Retained Earnings |
8
|
15
|
47
|
111
|
169
|
|
| Additional Paid In Capital |
0
|
0
|
414
|
433
|
512
|
|
| Other Equity |
0
|
0
|
0
|
2
|
1
|
|
| Total Equity |
4
N/A
|
7
N/A
|
366
+5 133%
|
321
-12%
|
344
+7%
|
|
| Total Liabilities & Equity |
1
N/A
|
16
+2 214%
|
380
+2 244%
|
364
-4%
|
380
+5%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
40
|
40
|
42
|
42
|
46
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
